Zobrazeno 1 - 10
of 64
pro vyhledávání: '"kaletra"'
Autor:
Najmolsadat Atefi, Azadeh Goodarzi, Taghi Riahi, Niloofar Khodabandehloo, Mahshid Talebi Taher, Niloufar Najar Nobari, Farnoosh Seirafianpour, Zeinab Mahdi, Amir Baghestani, Rohollah Valizadeh
Publikováno v:
Immunity, Inflammation and Disease, Vol 11, Iss 11, Pp n/a-n/a (2023)
Abstract Background The current absence of gold‐standard or all‐aspect favorable therapies for COVID‐19 renders a focus on multipotential drugs proposed to prevent or treat this infection or ameliorate its signs and symptoms vitally important.
Externí odkaz:
https://doaj.org/article/76a8b9053f974062b361494da69eed1c
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Haleh Rezaee, Fariba Pourkarim, Samira Pourtaghi‐Anvarian, Taher Entezari‐Maleki, Touraj Asvadi‐Kermani, Masoud Nouri‐Vaskeh
Publikováno v:
Pharmacology Research & Perspectives, Vol 9, Iss 1, Pp n/a-n/a (2021)
Abstract Drug‐drug interaction (DDI) is a common clinical problem that has occurred as a result of the concomitant use of multiple drugs. DDI may occur in patients under treatment with medications used for coronavirus disease 2019 (COVID‐19; i.e.
Externí odkaz:
https://doaj.org/article/e35737d5c30e412ca6b8bbcfa25d13d5
Autor:
Seyed Seifollah Beladi Mousavi, Fatemeh Hayati, Ehsan Valavi, Isa Rezaee, Shokouh Shayanpour, Leila Sabetnia
Publikováno v:
Journal of Preventive Epidemiology, Vol 5, Iss 2, Pp e28-e28 (2020)
A number of therapies are prescribed for the treatment of COVID-19, but none of them have proven efficacy. In this review article, we summarized the pharmacodynamic and pharmacokinetic properties, effect and potential toxicity of Kaletra (combination
Externí odkaz:
https://doaj.org/article/30136ffd4a314dee93acd427699fd34e
Autor:
Rohollah Valizadeh, Nahid Dadashzadeh, Roya Zakeri, Steven James Kellner, Mohsen Mohammad Rahimi
Publikováno v:
Journal of Nephropharmacology, Vol 9, Iss 2, Pp e21-e21 (2020)
Externí odkaz:
https://doaj.org/article/45103307d48b454fae0bc793397cc19b
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Saad Alhumaid, Abbas Al Mutair, Zainab Al Alawi, Naif Alhmeed, Abdul Rehman Zia Zaidi, Mansour Tobaiqy
Publikováno v:
Tropical Medicine and Infectious Disease, Vol 5, Iss 4, p 180 (2020)
(Background) Lopinavir-ritonavir (LPV/RTV) is a human immunodeficiency virus (HIV) antiviral combination that has been considered for the treatment of COVID-19 disease. (Aim) This systematic review aimed to assess the efficacy and safety of LPV/RTV i
Externí odkaz:
https://doaj.org/article/2cfcb79858a24c6487ede11de5eaa3a0
Autor:
Fariba Pourkarim, Taher Entezari-Maleki, Touraj Asvadi-Kermani, Haleh Rezaee, Samira Pourtaghi-Anvarian, Masoud Nouri-Vaskeh
Publikováno v:
Pharmacology Research & Perspectives
Pharmacology Research & Perspectives, Vol 9, Iss 1, Pp n/a-n/a (2021)
Pharmacology Research & Perspectives, Vol 9, Iss 1, Pp n/a-n/a (2021)
Drug‐drug interaction (DDI) is a common clinical problem that has occurred as a result of the concomitant use of multiple drugs. DDI may occur in patients under treatment with medications used for coronavirus disease 2019 (COVID‐19; i.e., chloroq
Autor:
Abdul Rehman Z. Zaidi, Mansour Tobaiqy, Saad Alhumaid, Zainab Al Alawi, Abbas Al Mutair, Naif Alhmeed
Publikováno v:
Tropical Medicine and Infectious Disease, Vol 5, Iss 180, p 180 (2020)
Tropical Medicine and Infectious Disease
Tropical Medicine and Infectious Disease
(Background) Lopinavir-ritonavir (LPV/RTV) is a human immunodeficiency virus (HIV) antiviral combination that has been considered for the treatment of COVID-19 disease. (Aim) This systematic review aimed to assess the efficacy and safety of LPV/RTV i
Autor:
Leila Sabetnia, Fatemeh Hayati, Ehsan Valavi, Shokouh Shayanpour, Seyed Seifollah Beladi Mousavi, Isa Rezaee
Publikováno v:
Journal of Preventive Epidemiology, Vol 5, Iss 2, Pp e28-e28 (2020)
A number of therapies are prescribed for the treatment of COVID-19, but none of them have proven efficacy. In this review article, we summarized the pharmacodynamic and pharmacokinetic properties, effect and potential toxicity of Kaletra (combination